CELINA PARAS: Open Payments
NPI 1891213195 · MERCEDES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,091 in 95 payments from 22 companies in 2025. Trend: 2023 $41 · 2024 $225 · 2025 $2,091
Food & beverage: $2,091
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $416 |
| Amgen Inc. | 12 | $235 |
| Sequel Med Tech, LLC | 6 | $219 |
| Xeris Pharmaceuticals, Inc. | 7 | $143 |
| Mannkind Corporation | 9 | $135 |
| Lilly USA, LLC | 7 | $123 |
| Insulet Corporation | 5 | $108 |
| Radius Health, Inc. | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Corcept Therapeutics | 3 | $66 |
Products named: Ozempic, TWIIST, EVENITY, AFREZZA, Omnipod, MOUNJARO, Tymlos, GVOKE HYPOPEN.
Industry payments across TX — which companies pay providers there.
